FASTKD5
FAST kinase domain-containing protein 5, mitochondrial
Also known as: FAKD5_HUMAN, FLJ13149
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7L8L6
- Gene
- FASTKD5
- Ensembl
- ENSG00000215251
- Chromosome
- 20
- Canonical length
- 764 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables rRNA binding activity. Involved in mitochondrial RNA processing. Located in mitochondrial nucleoid and ribonucleoprotein granule. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
764 residues, UniProt reviewed canonical sequence.
>Q7L8L6|FASTKD5
1 MAATLKSLKL VRYRAFCSPS AFGAVRSVSY WNVSSTQHGG QDPPEHISLC HSAKKVKNIC
61 STFSSRRILT TSSAHPGLEF SKTSSSKAST LQLGSPRATG VDEEDVEVFD SFENMRVFLQ
121 LRPEYRVHSY NASETSQLLS VSEGELILHK VRVNQNNLQA QVIVDYLCKL SSLPAEQHPV
181 LLGSTSFALL CQLSVKKIQL FDTQDLINVL KAFVILGIPH SHSMLDVYET KCCHQVWEMN
241 MDQLLLVADL WRYLGRKVPR FLNIFSSYLN LHWKDLSLSQ LVHLIYVIGE NRQVSQDLMQ
301 KLESLILKYI DLINLEEVGT ICLGFFKSST NLSEFVMRKI GDLACANIQH LSSRSLVNIV
361 KMFRFTHVDH INFMKQIGEI APQRIPSLGV QGVMHLTLYC SALRFLNEGV MNAVAASLPP
421 RVAHCRSKDV AKILWSFGTL NYKPPNAEEF YSSLISEIHR KMPEFNQYPE HLPTCLLGLA
481 FLEYFPVELI DFALSPGFVR LAQERTKFDL LKELYTLDGT VGIECPDYRG NRLSTHLQQE
541 GSELLWYLAE KDMNSKPEFL ETVFLLETML GGPQYVKHHM ILPHTRSSDL EVQLDVNLKP
601 LPFNREATPA ENVAKLRLEH VGVSLTDDLM NKLLKGKARG HFQGKTESEP GQQPMELENK
661 AAVPLGGFLC NVADKSGAME MAGLCPAACM QTPRMKLAVQ FTNRNQYCYG SRDLLGLHNM
721 KRRQLARLGY RVVELSYWEW LPLLKRTRLE KLAFLHEKVF TSALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FASTKD5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 32 nTPM
- bone marrow: 31 nTPM
- tongue: 25 nTPM
- heart muscle: 16 nTPM
- kidney: 15 nTPM
- adrenal gland: 13 nTPM
Single-cell type
- megakaryocytes: 12 nCPM
- platelets: 5.6 nCPM
- thymic myoid cells: 4.1 nCPM
- paneth cells: 3.9 nCPM
- endometrial secretory cells: 1 nCPM
- innate lymphoid cells: 0.9 nCPM
Immune cell
- basophil: 30 nTPM
- eosinophil: 20 nTPM
- naive CD8 T-cell: 18 nTPM
- MAIT T-cell: 18 nTPM
- non-classical monocyte: 18 nTPM
- T-reg: 18 nTPM
Brain region
- choroid plexus: 12 nTPM
- cerebellum: 11 nTPM
- pons: 8.7 nTPM
- cerebral cortex: 8.6 nTPM
- medulla oblongata: 7.9 nTPM
- white matter: 7.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FASTKD5.
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 111 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Leigh syndrome
- Mitochondrial complex IV deficiency, nuclear type 24
Disease | ImmuneIEDB
Conditions an epitope on FASTKD5 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FASTKD5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FASTKD5 as an antibody target. Whether an autoantibody or antibody against FASTKD5 could matter depends on whether native FASTKD5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FASTKD5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FASTKD5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...